NervGen Pharma Corp. (NGEN)
NASDAQ: NGEN · Real-Time Price · USD
1.540
0.00 (0.00%)
At close: Oct 20, 2026, 4:00 PM EDT
1.590
+0.050 (3.25%)
After-hours: Oct 20, 2026, 7:30 PM EDT
NervGen Pharma Market Cap
NervGen Pharma has a market cap or net worth of $165.58 million as of October 20, 2026. It is the 21,889th most valuable company in the world and the 3,720th biggest in the United States. Its market cap has decreased by 22.58% in one year.
Market Cap
165.58M
Enterprise Value
104.47M
1-Year Change
-22.58%
Global Rank
Country Rank
#3,720 United States
Category
ChartMarket Cap Chart
Since April 3, 2019, NervGen Pharma's market cap has increased from $37.43M to $165.58M, an increase of 342.39%. That is a compound annual growth rate of 21.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 165.58M | -62.85% |
| Dec 31, 2025 | 445.73M | 190.81% |
| Dec 31, 2024 | 153.27M | 26.05% |
| Dec 29, 2023 | 121.60M | 74.14% |
| Dec 30, 2022 | 69.83M | -27.73% |
| Dec 31, 2021 | 96.62M | 58.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 3, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ProQR Therapeutics | 184.87M |
| Invivyd | 182.34M |
| Sutro Biopharma | 181.40M |
| PepGen | 180.07M |
| Alpha Cognition | 178.36M |
| Sionna Therapeutics | 175.88M |
| Eledon Pharmaceuticals | 173.26M |
| Yarrow Bioscience | 170.36M |